Skip to main content
. Author manuscript; available in PMC: 2022 Aug 4.
Published in final edited form as: Mult Scler Relat Disord. 2022 May 28;63:103922. doi: 10.1016/j.msard.2022.103922

Figure 6:

Figure 6:

A panel of serum proteins classifies MS relapse with higher accuracy than sNfL alone. (A) Venn diagram comparing significantly-abundant proteins between MS Relapse and MS Remission from OMRF and Stanford cohort. (B) Table shows the five serum analytes that are significantly different between Relapse and Remission in OMRF and Stanford cohorts. (C) Receiver Operating Characteristics (ROC) curves examining the predictive performance of serum protein biomarkers for identifying MS relapse in the longitudinal cohort. (D) Table showing AUC scores, 95% CI, specificity, and sensitivity for all the regression models.